KINE-101

DRUG3 trials

Sponsors

Kine Sciences Co., Ltd.

Conditions

CIDP - Chronic Inflammatory Demyelinating PolyneuropathyHealthy Volunteers

Phase 1

A Phase 1 MAD Study of KINE-101 in Healthy Volunteers

CompletedNCT07324642

Kine Sciences Co., Ltd.Healthy Volunteers

Start: 2025-05-26End: 2025-08-25Updated: 2026-01-07

A First-in-Human Study of KINE-101 in Healthy Volunteers

CompletedNCT07343323

Kine Sciences Co., Ltd.Healthy Volunteers

Start: 2021-11-05End: 2023-01-31Updated: 2026-01-15

A First-in-Patient Clinical Trial of KINE-101 in Patients With Corticosteroid-Refractory CIDP

CompletedNCT07343310

Kine Sciences Co., Ltd.CIDP - Chronic Inflammatory Demyelinating Polyneuropathy

Start: 2024-08-27End: 2025-04-14Updated: 2026-01-20